Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3107 results found
Expand All
Apply All
3107 results found

“COVID-19 won’t be our last pandemic.”
Share
Good Day BIO Newsletter  •  February 22, 2021
As we start a new week, we’re focused on policy recommendations for beating COVID-19, preparing for the next pandemic, solving climate change, and building a resilient economy. (Yeah, we’re busy.) Details below, plus what’s happening in Washington this week and the Black chemist who paved the way for synbio. (1,000 words, 5 minutes)
Read More

BIO Letter to Minnesota State Senate on Supporting E15
Share
Agriculture & Environment, Sustainable Fuels  •  Letters, Testimony & Comments  •  February 21, 2021
On behalf of the Biotechnology Innovation Organization (BIO) – the world’s largest trade group for the biotechnology sector – I write to express support for Senate File 944, a bill you recently filed that would increase the minimum biofuel content in gasoline to 15 percent. BIO appreciates your leadership on this matter and stands ready to advocate for this important measure. Your legislation is extremely timely as most vehicles on the road today are newer than model year 2001 and thus compatible with E15; federal regulations now permit year-round use of E15; and E15 is seen as one of the most important near-term pathways to decarbonizing the transportation sector. To that end, corn-derived ethanol emits 46% less greenhouse gas emissions than conventional gasoline, according to a recent study by Environmental Health and Energy, Inc. based on research from Harvard, Tufts, and more than two dozen other institutions. SF 944 legislation builds on years of Minnesota’s commitment to supporting North Star State farmers, promoting rural economic development, and reducing carbon emissions. In 2003, Minnesota became the first state to require E10 gasoline. More recently, the Governor’s Council on Biofuels in early November of 2020 issued a consensus document outlining findings and recommendations that states, “moving from a 10 to 15 percent ethanol minimum content standard is a near term policy priority to accelerate progress toward the Petroleum Displacement Goal of 25 percent biofuel use in gasoline by 2030.” In closing, BIO thanks you for introducing SF 944 and looks forward to working with you and the countless other organizations that support the bill to see that it is enacted.
Read More

U.S. Regulatory Compliance eLearning Courses
Share
Browse the selection of online courses below, or click here to view all Center for Communication Compliance course offerings. 
Read More

Share
Browse the selection of online courses below, or click here to view all Center for Communication Compliance course offerings. 
Read More

Here is your copy of Clinical Development Success Rates and Contributing Factors 2011-2020
Share

Will the COVID-19 vaccines work against new strains?
Share
Good Day BIO Newsletter  •  February 19, 2021
So many amazing scientific breakthroughs this week—from NASA landing the Perseverance rover on Mars, to geneticists announcing they sequenced DNA from mammoth teeth that are 1 MILLION years old. We end the week by answering more questions about another amazing breakthrough—the COVID-19 vaccines—and explain how science is making our clothes more sustainable. (930 words, 4 minutes, 30 seconds)
Read More

What we need to do now
Share
Good Day BIO Newsletter  •  February 18, 2021
We have COVID-19 vaccines—but we’re not done yet. We also need to tackle vaccine hesitancy, health equity, and pandemic preparedness. Read to the end for insights for biotech investors and an introduction to a young Black chemist who achieved a number of firsts in her short life. (825 words, 4 minutes, 7 seconds)
Read More

Nasdaq’s CEO on biopharma, diversity, and GameStop
Share
Good Day BIO Newsletter  •  February 17, 2021
It’s Day 2 of the BIO CEO & Investor Digital Conference. We catch you up on yesterday’s conversation with Nasdaq President and CEO Adena T. Friedman, plus preview a new report on what’s driving clinical success rates. Read to the end for news, including a California bill that would incentivize biotech investment. (889 words, 4 minutes, 26 seconds)
Read More

What are biotech CEOs and investors thinking?
Share
Good Day BIO Newsletter  •  February 16, 2021
It’s Day 1 of the BIO CEO & Investor Digital Conference—follow our writers for all the news from the event. We also look at how biotech is marking Black History Month—and why understanding our past is so important to ensuring equitable access to science in the future. As usual, you’ll find news links and the BIO Beltway Report at the end. (777 words, 3 minutes, 53 seconds)
Read More

Tackle climate change, create jobs, preserve innovation
Share
Good Day BIO Newsletter  •  February 12, 2021
To close out the week, we explain the Biden administration’s new climate working group and how to protect America’s innovation ecosystem. And because it’s almost Valentine’s Day, we recognize the Black inventor who has saved hundreds of thousands of hearts. (892 words, 4 minutes, 27 seconds) Good Day BIO is taking a break on Monday, February 15, for Presidents Day. We will resume normal publication on Tuesday, February 16.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 190
  • 191
  • 192
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO